VF
ACET icon

Virtu Financial’s Adicet Bio ACET Stock Holding History

Virtu Financial’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,995
Closed -$65K – 1590
2025
Q3 		$65K Buy
+4,995
New +$58.9K ﹤0.01% 1099
2025
Q2 		– Sell
-1,483
Closed -$18K – 1387
2025
Q1 		$18K Sell
1,483
-430
-22% -$6.15K ﹤0.01% 1113
2024
Q4 		$29K Buy
+1,913
New +$36.1K ﹤0.01% 1241
2023
Q3 		– Sell
-1,006
Closed -$39K – 1217
2023
Q2 		$39K Buy
+1,006
New +$88.8K ﹤0.01% 1171
2022
Q1 		– Sell
-1,268
Closed -$355K – 1442
2021
Q4 		$355K Buy
+1,268
New +$218K 0.04% 531
2020
Q3 		– Sell
-264
Closed -$64K – 990
2020
Q2 		$64K Buy
+264
New +$51.9K 0.01% 969
2019
Q4 		$21K Buy
+125
New +$63.3K ﹤0.01% 1317

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Virtu Financial's ACET Position: Q4 2025 in Review

Virtu Financial sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 4,995 shares — an estimated $65K sold.

Virtu Financial first reported a position in ACET in Q4 2019 and held it in 7 quarters. The position peaked at $355K in Q4 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Virtu Financial reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 4,995 Adicet Bio shares in Q4 2025, an estimated $65K.
  • Virtu Financial first reported a position in Adicet Bio in Q4 2019 and held it in 7 quarters.
  • Virtu Financial's Adicet Bio position peaked at $355K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.